• Police seek suspects in deadly birthday party shooting
  • Lawmakers launch inquires into U.S. boat strike
  • Nov. 29, 2025, 10:07 PM EST / Updated Nov. 30, 2025,…
  • Mark Kelly says troops ‘can tell’ what orders…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

Sept. 27, 2025, 7:30 AM EDTBy Jared PerloNEW YORK — The United States clashed with world leaders over artificial intelligence at the United Nations General Assembly this week, rejecting calls for global oversight as many pushed for new collaborative frameworks.While many heads of state, corporate leaders and prominent figures endorsed a need for urgent international collaboration on AI, the U.S. delegation criticized the role of the U.N. and pushed back on the idea of centralized governance of AI.Representing the U.S. in Wednesday’s Security Council meeting on AI, Michael Kratsios, the director of the Office of Science and Technology Policy, said, “We totally reject all efforts by international bodies to assert centralized control and global governance of AI.”The path to a flourishing future powered by AI does not lie in “bureaucratic management,” Kratsios said, but instead in “the independence and sovereignty of nations.”While Kratsios shot down the idea of combined AI governance, President Donald Trump said in his speech to the General Assembly on Tuesday that the White House will be “pioneering an AI verification system that everyone can trust” to enforce the Biological Weapons Convention.“Hopefully, the U.N. can play a constructive role, and it will also be one of the early projects under AI,” Trump said. AI “could be one of the great things ever, but it also can be dangerous, but it can be put to tremendous use and tremendous good.”.In a statement to NBC News, a State Department spokesperson said, “The United States supports like-minded nations working together to encourage the development of AI in line with our shared values. The US position in international bodies is to vigorously advocate for international AI governance approaches that promote innovation, reflect American values, and counter authoritarian influence.”The comments rejecting collaborative efforts around AI governance stood in stark contrast to many of the initiatives being launched at the General Assembly.On Thursday, the U.N. introduced the Global Dialogue on AI Governance, the U.N.’s first body dedicated to AI governance involving all member states. U.N. Secretary-General António Guterres said the body would “lay the cornerstones of a global AI ecosystem that can keep pace with the fastest-moving technology in human history.” Speaking after Guterres, Nobel Prize recipient Daron Acemoglu outlined the growing stakes of AI’s rapid development, arguing that “AI is the biggest threat that humanity has faced.”But in an interview with NBC News, Amandeep Singh Gill, the U.N.’s special envoy for digital and emerging technologies, told NBC News that the United States’ critical perception of the U.N.’s role in international AI governance was misconstrued.“I think it’s a misrepresentation to say that the U.N. is somehow getting into the regulation of AI,” Gill said. “These are not top-down power grabs in terms of regulation. The regulation stays where regulation can be done in sovereign jurisdictions.”Instead, the U.N.’s mechanisms “will provide platforms for international cooperation on AI governance,” Gill said.In remarks immediately following Kratsios’ comments, China’s Vice Minister of Foreign Affairs Ma Zhaoxu said, “It is vital to jointly foster an open, inclusive, fair and nondiscriminatory environment for technological development and firmly oppose unilateralism and protectionism.”“We support the U.N. playing a central role in AI governance,” Ma said.One day after Kratsios’ remarks at the Security Council, Spanish Prime Minister Pedro Sánchez seemed to push back on Kratsios and gave full-throated support for international cooperation on AI and the U.N.’s role in AI governance.“We need to coordinate a shared vision of AI at a global level, with the U.N. as the legitimate and inclusive forum to forge consensus around common interests,” Sánchez said. “The time is now, when multilateralism is being most questioned and attacked, that we need to reaffirm how suitable it is in addressing challenges such as those represented by AI.”Reacting to the week’s developments, Renan Araujo, director of programs for the Washington, D.C.-based Institute for AI Policy and Strategy, told NBC News that “no one wants to see a burdensome, bureaucratic governance structure, and the U.S. has succeeded in starting bilateral and minilateral coalitions. At the same time, we should expect AI-related challenges to become more transnational in nature as AI capabilities become more advanced.”This is not the first time the U.N. has addressed AI, having passed the Global Digital Compact last year. The compact laid the foundation for the AI dialogue and for an independent international scientific panel to evaluate AI’s abilities, risks and pathways forward. Guterres announced that nominations to this panel are now open.While Thursday’s event marked the launch of the global dialogue and panel, the dialogue will have its first full meeting in Geneva in summer 2026, in tandem with the International Telecommunication Union’s annual AI for Good summit. The dialogue’s exact functions and first actions will be charted out over the coming months.Jared PerloJared Perlo is a writer and reporter at NBC News covering AI. He is currently supported by the Tarbell Center for AI Journalism.

admin - Latest News - September 27, 2025
admin
30 views 11 secs 0 Comments




The United States clashed with world leaders over artificial intelligence at the United Nations General Assembly this week.



Source link

TAGS:
PREVIOUS
Sept. 27, 2025, 5:30 AM EDTBy Berkeley Lovelace Jr.For people who rely on certain prescription drugs, including weight loss, asthma and cancer medications, President Donald Trump’s post announcing 100% tariffs on foreign brand-name drugs offers little clarity on when — or if — medications might see price hikes. “Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America,” Trump said on Truth Social late Thursday. “‘IS BUILDING’ will be defined as, ‘breaking ground’ and/or ‘under construction.’ There will, therefore, be no Tariff on these Pharmaceutical Products if construction has started.”Experts say Trump’s post raises a lot of questions. Here are five major ones. What drugs will be impacted?Trump’s post doesn’t specify whether brand-name drugmakers with an existing U.S. plant would be exempt, whether that exemption would include all their products, or whether it would only be for the drugs manufactured at the U.S. site. Novo Nordisk and Eli Lilly, makers of the weight loss drugs Wegovy and Zepound, respectively, have announced plans to invest in U.S. manufacturing. But it’s unclear if their intent to invest will warrant an exemption. On Tuesday, Lilly announced plans for a $6.5 billion manufacturing facility in Houston that will produce Zepbound and its other GLP-1 drug, Mounjaro, following a recent commitment to build a $5 billion plant near Richmond, Virginia. Novo Nordisk, a Danish company, said in June it would spend $4.1 billion to construct a second GLP-1 fill-finish plant in Clayton, North Carolina.AstraZeneca, which makes the asthma drug Symbicort, also announced in July that it will invest $50 billion over the next five years to expand its research and development and manufacturing footprint in the U.S. Many other popular brand-name drugs, however, are primarily manufactured overseas, particularly in Europe, said Rena Conti, an associate professor at Boston University’s Questrom School of Business.Botox, made by Allergen, and the cancer drug Keytruda from drugmaker Merck are made in Ireland. (Keytruda’s manufacturing has increasingly moved to the United States in recent years, but it’s not clear if that would earn an exemption from Trump’s tariffs.)Others, including some for blood and lung cancers, as well as vaccines, are made in places like India and China, Conti said. “I think what’s most at risk here are branded products that come from China and India,” she said. The E.U. and Japan already have trade agreements in place that cover pharmaceuticals, she added, and it’s unclear whether the new tariff will supersede that. Will patients see prices increase?Only 1 in 10 of the prescriptions filled in the U.S. are for brand-name drugs; the vast majority are for generics, which are much cheaper and will not be affected by these tariffs. Whether patients see price increases will depend on how many drugmakers receive exemptions — and on whether companies choose to pass those costs on to patients at the pharmacy counter, said Dr. Aaron Kesselheim, a professor of medicine at Harvard Medical School. ​​“Ultimately, tariffs are taxes on patients,” Kesselheim said, “and to the extent that drug companies see increases in cost due to tariffs, they will pass those costs on to patients.”Some companies may decide not to pass the costs along. So far, the 15% tariffs on imports from the E.U. haven’t translated into big price hikes for U.S. patients, Conti noted. To be sure, a 100% tariff would be far more costly for a company. Price hikes may not start right away, as drugmakers find out whether they qualify for an exemption. There also might be a lag since U.S. law prevents drugmakers from increasing the price of drugs faster than inflation.“What if you’re doing updates to the plant you currently have? What if you’re planning a facility? Do those count?” Kesselheim said. “It’s all very ambiguous.”Some patients may not notice additional price hikes at all, given how costly brand-name drugs already are in the U.S., said Arthur Caplan, the head of the Division of Medical Ethics at NYU Langone Medical Center in New York City. “I can certainly predict that some patients will immediately feel price increases that will shock them on some of these drugs,” Caplan said.Could insurers absorb the costs?Insurers and middlemen, known as pharmacy benefit managers, could try to negotiate drugmakers or absorb some of the tariff-related costs, Caplan said.It’s more likely, however, that they’d pass it on to patients in the short term, potentially in the form of a larger copay, he said.It’s not only patients with private insurance that should be worried about price hikes, Kesselheim said. Those who get their drugs covered through government health programs could also see price increases.“The government is the largest purchaser of prescription drugs in the market, through Medicare, Medicaid and the VA, so it’s really the government or government payers that are going to see the largest impact on price increases,” he said. Will tariffs spur more U.S. drug manufacturing?It’s unlikely, Kesselheim said. The decision to build a plant “is a complicated and expensive one” that requires several regulatory hurdles and years of planning.Conti noted that by the time new manufacturing plants are completed, Trump would likely be out of office.“It is somewhere between two years and five years to get new production facilities built,” she said, “and it can be in the millions of dollars depending on whether the product that you’re making is a small molecule drug or a biologic.”Even putting money back into an existing plant isn’t quick.“If you want to switch a line or retool a factory to make a product, then we’re talking about somewhere between 18 to 36 months to do that,” Conti said, “because you have to show the U.S. regulator that you can make it at this factory at scale, and the product is what it says it is, or is high quality and meets the quality standards of the U.S.”In a statement, Alex Schriver, a spokesperson for the trade group the Pharmaceutical Research and Manufacturers of America, said “most innovative medicines prescribed in America are already made in America” and companies continue to invest in the U.S.“Tariffs risk those plans because every dollar spent on tariffs is a dollar that cannot be invested in American manufacturing or the development of future treatments and cures,” Schriver said. “Medicines have historically been exempt from tariffs because they raise costs and could lead to shortages.”What about shortages?If Trump keeps his focus solely on brand-name drugs, U.S. patients are unlikely to face shortages, Kesselheim said.“Their profits are just so, so far beyond this tariff cost that they could probably be OK or raise the prices of the drugs,” he said. “They would probably not stop production as a result.”But that excludes, he added, some smaller companies who may make niche brand-name products and may not have the resources to take on the extra costs. If tariffs extend to generics, the risk is far greater, Caplan added. Unlike brand-name drugs, generic drugs are typically sold at close to the cost they’re made, he said, which makes it difficult for companies to justify the cost of building a new facility. They’d likely be forced to walk away from production or close their plants altogether.Berkeley Lovelace Jr.Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
NEXT
Sept. 27, 2025, 9:29 AM EDTBy Freddie ClaytonThe giants of the Amazon are getting even bigger. A sweeping new study has found the rainforest’s largest trees are not only holding their ground, they’re thriving — growing, multiplying in number and continue to play a major role in mitigating the impacts of climate change.There was a 3.3% expansion in big trees per decade, scientists found, after tracking changes in 188 intact forest plots across the Amazon over the past 30 years.Led by almost 100 researchers from 60 universities in Brazil, the U.K. and elsewhere, the findings were published on Thursday in the journal “Nature Plants.”The authors attributed the growth to the rising amount of carbon dioxide in the atmosphere from the burning of gas, oil and coal.The paper was welcomed as evidence of forest resilience in the face of climate change, but scientists warned these big trees remain vulnerable as droughts, lightning and fires are increasing in frequency, while deforestation continues to pose a serious threat.There was an understanding that big trees were “expected to be vulnerable to climate change,” Adriane Esquivel-Muelbert, one of the study’s lead authors told NBC News in a telephone interview Saturday. “What we see here is actually they seem to be showing quite a resilience.”“We’re not seeing signs of them dying off,” Esquivel-Muelbert, who co-authored the study while at Britain’s University of Birmingham, but who has since moved on to the nearby University of Cambridge. “They are increasing in size and number as well.”Scientists stressed that while protecting intact forest areas was essential to stabilizing the climate, the Amazon cannot on its own offset the vast amount of carbon dioxide produced worldwide by cars, factories and power stations — and it remains under threat.The rainforest is a carbon sink, meaning it stores more carbon than it produces. Pushing the rainforest past its limit could accelerate climate change and have terrible consequences for local communities, including Indigenous groups who depend on it. Esquivel-Muelbert stressed it was difficult to predict how worsening climate change would have an impact in the future, and hesitated to say that increased CO2 benefitted the forest, warning it may cause bigger trees to become more exposed to other factors like drought.”We don’t know the consequences in the long run,” she said. Other factors, including deforestation, remain a colossal risk to the health of the Amazon. Fattening trees is, in some ways, a “positive news story,” said Rebecca Banbury Morgan, a lead author of the study from the University of Bristol. But it also means that the forest is now “more vulnerable to losing those trees.” “Although we have shown that trees in intact forest are still increasing in size, any benefits of this in terms of the carbon sink can be quite easily negated by deforestation and logging impacts, so preserving these intact forests is really a priority,” she told NBC News. Wildfires, deforestation and global warming could permanently destroy the water cycle that sustains parts of the Amazon rainforest if action is not taken in the coming decades, according to a separate study published last year in Nature.The study suggested that 10% to 47% of the landscape is at risk of transitioning away from rainforest by 2050 if warming and rates of deforestation aren’t dramatically curbed.Brazil’s Congress approved a bill in 2023 to relax environmental licensing to pave a highway cutting through the heart of the Amazon, and close to one of the last regions that still has large areas of pristine forestLosing a large portion of the Amazon could turn a key carbon sink into a source of emissions, as wildfires burn and plants and animals decompose, no longer able to survive. Freddie ClaytonFreddie Clayton is a freelance journalist based in London. 
Related Post
September 22, 2025
The Philippines braces for Super Typhoon Ragasa
November 3, 2025
Nov. 3, 2025, 5:00 AM ESTBy Sahil Kapur and Brennan LeachPORTLAND, Maine — In the last three weeks, Graham Platner has faced enough damaging revelations to potentially sink just about any candidate. The Democratic Senate hopeful has apologized for past online posts making offensive comments, covered up a tattoo on his chest that has a Nazi association and lost top staff.Yet Platner is still standing.The 41-year-old oyster farmer and combat veteran spoke to a packed crowd at the State Theatre here on Sunday, counted at 745 attendees by his campaign, about his vision for “building power.”“It is amusing for me to watch the campaign described in the media as collapsing or falling apart — when internally, we frankly have not felt this strong since the beginning,” Platner told NBC News after the event. “It hasn’t sunk my campaign. In fact it seems, in many ways, it’s strengthened us.”He said that’s because he has addressed his past head-on and not run from it. “I want to talk about my evolution as a human being,” he said. “A lot of Americans also want to have hope that you can change and that you can evolve, and that we can have a society that gives grace and forgiveness to people. Because if we can’t, if we think that people are just ossified into who they are right now, and can never be something different, then what’s the point?”The Maine Senate race is shaping up to be one of the key fights of the 2026 midterms, with Platner trying to take advantage of the restlessness in the Democratic Party. A progressive populist who has the support of Sen. Bernie Sanders, I-Vt., Platner is running on a platform of universal health care, housing affordability and ending U.S. involvement in foreign wars.In a wide-ranging interview, Platner addressed the scandals that have engulfed his campaign and said he’s “very proud of who I am today” after the “arcs and valleys” of his life. He inveighed against “establishment politics,” dished on his tense relationship with national Democratic leaders, made the case that he’s more “electable” than Democratic Gov. Janet Mills and explained why he went from voting for Republican Sen. Susan Collins years ago to viewing her as an empty vessel today.Platner also said he isn’t lamenting his staff departures, which include his political director and finance director.“We find ourselves now in a significantly stronger position, team-wise,” he said. “While we lost some people, we’ve kept almost everybody, and people that have stayed are galvanized and committed.”“It is amusing for me to watch the campaign described in the media as collapsing or falling apart — when internally, we frankly have not felt this strong since the beginning,” Platner told NBC News after the event.Brennan Leach / NBC NewsA dozen rally attendees — including some who supported Collins in the past — said they don’t consider Platner’s past comments disqualifying. Some voters said it gave them pause and they’re undecided; others said they accept his explanations and plan to vote for him in the primary.“It gave me pause, but I read his responses and I’m still intrigued to hear more about him,” said Emily Bukowski-Thall, of Portland, Maine.Her husband, Michael Bukowski, added, “If you look at the controversies surrounding the current president, this is nothing.”Platner responded to the pitch from Mills and Senate Minority Leader Chuck Schumer, D-N.Y., that the two-term governor is a battle-tested and safe option to unseat Collins.“I think my ‘lack of experience’ is a positive,” he said. “People don’t want establishment politicians. People don’t want to see the same playbook run over and over and over again — a playbook which, by the way, has failed to unseat Susan Collins time after time. I firmly believe that the real risk is running an establishment candidate that is not trying something new.”In response, Mills campaign spokesperson Scott Ogden said in a statement, “Governor Mills is the only Democrat in this race who has stood up to Donald Trump, who has won two statewide elections, and who has delivered real results for working Maine families — including expanding health care to more than 100,000 Maine people, fully funding education, guaranteeing free school meals, delivering free community college, protecting abortion rights, and fighting climate change.”While some attendees at Sunday’s rally said the 77-year-old Mills is too old for their taste, Platner said that isn’t his concern: “This is not about age. It is about how old your ideas are.”Platner said he has received no outreach from Schumer or Sen. Kirsten Gillibrand, D-N.Y., the chair of the Democratic Senatorial Campaign Committee, or from DSCC staff. “We have made it very clear that I’m very open to those discussions. But no, no one has reached out,” he said, while adding that he would welcome the support of the deep-pocketed DSCC in a general election. “We have been very clear that we are not trying to have a friction-filled relationship, though that has been rebuffed on multiple occasions… The ball is in their court.”NBC News reached out to the DSCC for comment.Platner said he has “voted for Susan Collins at least once, possibly twice” but “it was a long time ago” — as the 72-year-old incumbent closes in on 30 years in the Senate.“I also believed back then that she was a moderate. As time has gone by, I don’t believe that. I think that’s a charade, and it’s worn thin,” he said. “I see Collins as, frankly, just another self-interested, establishment politician who uses this kind of myth of their moderation to stay in power, but doesn’t really do anything with their power. She’s the chair of the Appropriations Committee. I was told for years that when she got the gavel, there was going to be a boon of riches for the state of Maine. That is not materializing.”Graham Platner’s campaign told NBC News that 745 people were in attendance Sunday night.Brennan Leach / NBC NewsCollins spokesperson Blake Kernen noted that she has been ranked multiple times by the Lugar Center and Georgetown’s McCourt School of Public Policy as the most bipartisan U.S. senator. In addition, Collins’ Senate website highlights that she has secured more than $1 billion in congressionally directed spending for projects in Maine over the last three fiscal years.Elizabeth Lardie Thompson, an attendee of the rally from Bath, Maine, said she felt “very betrayed” by Collins after voting for her. She pointed to Collins’ support of conservative Supreme Court Justice Brett Kavanaugh and “not listening” to her constituents on health care. “I think she’s beholden to her party much more than she’s beholden to her state,” Thompson said. “I really don’t care; red, blue, whatever, but I do have a problem with how Collins has handled herself recently.”Cathay Getchell from Scarborough, Maine, also previously voted for Collins, but she said that she is concerned about the senator’s age and alignment with the “establishment” of the Republican Party. “She’s been there too long and we need a change,” Getchell said outside of the rally. Collins has picked her moments to break with the GOP, like in opposing President Donald Trump’s “big, beautiful bill” to extend tax breaks and cut Medicaid spending. But she also gives the GOP a valuable vote to ensure the Senate remains controlled by Trump’s allies. As she seeks another six-year term in this blue-leaning state, Collins is expected to run another local campaign and tout the money she has brought home to Maine.“Her primary role at this point is to function as cover for the Republicans to maintain a majority of the Senate,” Platner said. “I think that her votes on Brett Kavanaugh and her votes on RFK Jr. show that she is not interested in actually holding up the moderate side of the moderate bargain, and that we deserve better.”A few weeks ago Collins slammed Platner’s since-deleted Reddit posts from 2020 and 2021 after they were reported by CNN, calling them “terrible” and “really offensive.”“I was appalled when I read those comments,” she told Maine reporters. “First of all, as someone who comes from rural Maine, for him to have described white people living in rural Maine as racist and stupid. Just the opposite is the case.”Asked to respond, Platner said he “did not denigrate white, rural older voters.”“I did get in a fight with somebody and say that some rural white voters were stupid and racist,” he said, adding that anybody who reads those posts will see that he defends them more than he criticizes them. “I myself am a rural white voter in eastern Maine. These are my neighbors and my friends. I actually rise to their defense often and continue to do so.”“I don’t want to be flippant about it, but I was getting in arguments on the Internet … at a part in my life when I was looking for interaction and engagement, at a time where I was feeling quite isolated and alone and very disillusioned at that point,” he added. “I do not hold those feelings.”In one of his posts, Platner wrote, “I got older and became a communist.” He said he has never considered himself to be a communist and that the comment was merely “Internet shitposting — and also … if you read it’s very clear that I’m joking.”“I believe in Medicare for all. I believe in expanding the rights of workers to organize. I believe in taxing the ultra-rich. I believe in a fairer economic system,” he said. “I also know that because I believe in those things, people will refer to me as that no matter what… That’s the joke.”Sahil KapurSahil Kapur is a senior national political reporter for NBC News.Brennan LeachBrennan Leach is an associate producer for NBC News covering the Senate.
November 1, 2025
Savewith a NBCUniversal ProfileCreate your free profile or log in to save this articleNov. 1, 2025, 6:42 AM EDTBy Chloe Atkins and Corky SiemaszkoWhen former NBA player Damon Jones, who has been accused of feeding inside information to sports gamblers, first filed for bankruptcy in 2013, he had to list his Yorkshire Terrier as an asset.The unnamed pooch was valued, according to the court documents, at just $1.A decade later, Jones was a few months away from being evicted from a luxury Houston apartment building when prosecutors allege he texted a co-conspirator and urged him to bet on the Milwaukee Bucks against the Los Angeles because a top Lakers player, believed to be LeBron James, was out with an injury. Jones went from relative anonymity as a former NBA player and coach to the forefront of one of the biggest gambling scandals in modern sports when he was named by federal prosecutors last week in two separate indictments allegedly involving gambling and fixed, mob-linked poker games. NBC News reviewed more than 150 pages of court documents from Jones, including financial forms, spanning more than a decade that show persistent financial problems for the ex-athlete. In addition to the eviction proceedings, Jones listed his 2016 NBA championship ring as collateral for a personal loan and was hundreds of thousands of dollars in debt. “Operation Nothing But Bet” is one of two sprawling federal investigations into illegal gambling that were unveiled Oct. 23, the other being a probe of rigged high-stakes poker games allegedly backed by the Mafia called “Operation Royal Flush” which led to the arrests of several people, including Portland Trail Blazers head coach Chauncey Billups. Prosecutors said the evidence in the latter case includes “financial records, telephone records, cellphone records and texts, cellphone extractions and location information, the contents of Apple iCloud accounts, witness testimony, and surveillance photographs.”Jones has yet to enter a plea, but is due in federal court for his arraignment in New York. Jones’ lawyer declined to comment. Jones’ current address, according to available records, appears to be the Houston apartment that a property management company tried to evict him from in June 2023, claiming he owed around $5,600 in rent, records show.The management company dismissed the case after Jones failed to appear in court. But in August 2023, the company filed another eviction notice against Jones, this time claiming he owed more than $11,000 in back rent. Once again, Jones failed to appear in court and the judge issued a default judgment in favor of the company, granting it possession of the apartment and slapping Jones with a monetary judgment of $11,240, records show. When the court tried to mail Jones a copy of the default judgment, the notice was returned due to an insufficient address. The management company has not responded to NBC News’ request for comment. Jones’ financial woes go back at least to 2013, when his initial bankruptcy case was dismissed. Two years later, Jones filed for bankruptcy again and this time, according to court records, he reported $500,000 to $1 million in liabilities and claimed to have assets in the range of $100,001 to $500,000.Jones, those records showed, owed around $640,000 to creditors and $47,000 to the Bellagio Hotels and Casino for “breach of contract/confession of judgement.”It’s not clear what happened with that bankruptcy case. Bellagio did not respond to an inquiry from NBC News. But in 2019, another man who said Jones owed him money surfaced, court records show.Scott Kerr filed a civil complaint against Jones seeking monetary relief of $100,000 or less. According to the filing, Jones borrowed $10,000 from Kerr. That, plus a $4,000 fee, was supposed to be paid by Aug. 28, 2017.Jones failed to pay back the loan and the collateral Jones put up to secure the loan from Kerr was his 2016 NBA championship ring, according to the filing, which added that he also failed to provide the collateral.Kerr wasn’t the only person Jones allegedly stiffed. Between October 2023 and November 2024, Jones was hit with complaints from three men saying he failed to repay them thousands of dollars in loans. One of them, Antonio Hooper, said in a November 2024 filing that Jones had agreed in writing to pay him $20,000 in return for a $4,500 loan. His filing included screenshots of text exchanges with Jones, including one in which the former NBA player mentions “Bron” being unable to “get over that Sports Illustrated article he did.” Hooper, in a telephone interview, said Jones never paid him back. He said the reason he was asking for $20,000 is that he lent Jones more money after the initial $4,500 loan. He also said he and Jones have mutual friends in the NBA.“I don’t know what article Damon was talking about,” said Hooper, who said he runs a youth basketball program in Houston. “But I have a friend who was looking for a job in the NBA and Damon put him on the phone with LeBron for an interview. He didn’t get the job and LeBron didn’t like Damon trading on his name. He didn’t appreciate that.”James did not immediately respond to a request for comment via the Lakers.Jones was one of more than 30 people arrested in the operations. Also nabbed was Miami Heat guard Terry Rozier, who is accused of faking an injury to take himself out of a game in 2023 when he played for the Charlotte Hornets, giving a heads up to a friend who, in turn, “sold that tip” to gamblers betting on that Hornets versus New Orleans Pelicans game.Like Jones, Rozier is charged with conspiracy to commit wire fraud and conspiracy to commit money laundering. And like Jones, Rozier too, has had money problems. In 2023, the IRS filed a federal tax lien in Florida against Rozier for $8.2 million in unpaid taxes from 2021. In August 2022, a construction company filed a lien against Rozier for over $270,000, according to a claim filed in Florida. A year later, Rozier paid off the lien except for $20,000, court documents showed.Rozier has yet to enter a plea to the federal charges. Rozier’s attorney pushed back on allegations that his client owed millions to the government.“The federal tax lien story is a nothing-burger. His total tax liability was about $8 million. Between the CPAs and the IRS, something happened with his electronic filing, so the IRS issued a lien on the entire amount. The actual tax deficiency ended up being $3,000, and that has been paid off. We expect the now-defunct lien to be removed in the near future,” Rozier’s attorney Jim Trusty said on Friday. Chloe AtkinsChloe Atkins reports for the NBC News National Security and Law Unit, based in New York.Corky SiemaszkoCorky Siemaszko is a senior reporter for NBC News Digital.Tom Winter contributed.
November 19, 2025
Larry Summers faces fallout over Epstein emails
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved